Terminal lung cancer patients accessing medication faster thanks to Canadian first laboratory test
A first of its kind laboratory test in Canada validated at London Health Sciences Centre (LHSC) and made possible by research at Lawson Health Research Institute provides patients with non-small cell lung cancer a non-invasive option to be tested for a gene mutation and receive life-extending second...